Robert Klupacs

Part of Merck & Co., Inc., Amrad Pharmaceuticals Pty Ltd. develops pharmaceutical products. The company is based in Kew, Australia. Amrad Pharmaceuticals was acquired by Merck & Co., Inc. from CSL Innovation Pty Ltd. on September 05, 2000 for $11.98 million.

Syngene Ltd. is an integrated research, development, and manufacturing services company based in India. The Australian company serves various sectors such as pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemicals. Syngene has over 6000 scientists who offer great science, robust data security, and quality manufacturing to improve time-to-market and lower the cost of innovation. The private company has dedicated research facilities for Amgen, Baxter, Bristol-Myers Squibb, and Herbalife, as well as 1.9 million square feet of specialist discovery, development, and manufacturing facilities. Syngene works with biotech companies pursuing leading-edge science as well as multinationals including GSK and Merck KGaA.

ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore.

Bionics Institute is an independent medical research institute, affiliated with the University of Melbourne, undertaking medical bionics research and It focus particularly on neural prostheses. The company was founded by Graeme Clark on August 29,1984 and is headquartered in East Melbourne, Australia.

Pharmaceuticals Industry Council was a non-profit organisation. The company has been forum for developing, evaluating and providing expert advice to government on issues affecting the Australian pharmaceuticals industry. It brought together senior executives from companies and peak bodies representing three industry sectors, including the research-based and generic medicines sectors and the biotechnology sector. The company was founded in 2006 and is headquartered in Deakin, the United Kingdom.